Latest Articles
Latest
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Resources from Leukemia & Lymphoma Society
A new Bloodline podcast episode from the Leukemia & Lymphoma Society (LLS), features the topic of exercise. Moving the body can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park...
Accelerate the Cure News
Accelerate the Cure is much more than a campaign slogan. It’s our next 31 million USD effort, over five years, to find a cure and support those with WM and their caregivers. Global researchers have a new set of WM research targets, and they are afire with excitement....
2024 Walk for Waldenstrom’s Launches
Now that the 2024 Walk for Waldenstrom’s has officially launched, we're lacing up our shoes, starting fundraisers, and spreading the word that we will find a cure. Every year, during Blood Cancer Awareness Month, September 2024, we come together to show our support...
August Is National Make-A-Will Month
Did you know August is National Make-A-Will Month? By creating your will this month, you can get peace of mind for the future, protect your family, and support the future of the IWMF. Nearly 67% of American adults don't have a will, and we’re sharing a free, online...
IWMF ANNOUNCES 2024 RESEARCH GRANT RECIPIENTS
IWMF has committed to the biggest package of research since its inception. Our vision—A world without WM—is finally within reach as summarized by Dr. Steven Treon, of Dana-Farber Cancer Institute, "Once we do a better job at shutting down the signaling of that mutated...
Addition to the WM Physicians Directory in the U.S. – Peter Foresberg
IWMF Announces an Addition to the WM Physicians Directory in the U.S.For your convenience in seeking a consultation for a second opinion, we provide a directory of well-known cancer centers we work with and physicians/researchers who are very knowledgeable about WM....
Subscribe Today!
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean scelerisque suscipit condimentum. Vestibulum in scelerisque eros. Fusce sed massa vel sem commodo.
Featured Story
Lorem ipsum dolor sit consectetur adipiscing elit.
Proin eget tortor risus. Praesent sapien massa, convallis a pellentesque nec, egestas non nisi. Curabitur aliquet quam id dui posuere blandit. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Sed porttitor lectus nibh. Cras ultricies ligula sed magna dictum porta. Proin eget tortor risus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Nulla quis lorem ut libero malesuada feugiat.
Pellentesque in ipsum id orci porta dapibus. Nulla porttitor accumsan tincidunt. Nulla quis lorem ut libero malesuada feugiat. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Donec velit neque, auctor sit amet aliquam vel, ullamcorper sit amet ligula. Vivamus suscipit tortor eget felis porttitor volutpat. Proin eget tortor risus. Cras ultricies ligula sed magna dictum porta. Proin eget tortor risus. Vivamus suscipit tortor eget felis porttitor volutpat.
Featured Author
Vestibulum Malesuada Non Magna Lacinia
Proin eget tortor risus. Praesent sapien massa, convallis a pellentesque nec, egestas no
Staff Picks
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Resources from Leukemia & Lymphoma Society
A new Bloodline podcast episode from the Leukemia & Lymphoma Society (LLS), features the topic of exercise. Moving the body can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Resources from Leukemia & Lymphoma Society
A new Bloodline podcast episode from the Leukemia & Lymphoma Society (LLS), features the topic of exercise. Moving the body can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park...
Accelerate the Cure News
Accelerate the Cure is much more than a campaign slogan. It’s our next 31 million USD effort, over five years, to find a cure and support those with WM and their caregivers. Global researchers have a new set of WM research targets, and they are afire with excitement....
2024 Walk for Waldenstrom’s Launches
Now that the 2024 Walk for Waldenstrom’s has officially launched, we're lacing up our shoes, starting fundraisers, and spreading the word that we will find a cure. Every year, during Blood Cancer Awareness Month, September 2024, we come together to show our support...
August Is National Make-A-Will Month
Did you know August is National Make-A-Will Month? By creating your will this month, you can get peace of mind for the future, protect your family, and support the future of the IWMF. Nearly 67% of American adults don't have a will, and we’re sharing a free, online...
Popular Categories
Categories
Gadgets & Devices
Fashion
Travel
Trending Now
Hot
Latest Trending
Featured Trending
Staff Picks
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Resources from Leukemia & Lymphoma Society
A new Bloodline podcast episode from the Leukemia & Lymphoma Society (LLS), features the topic of exercise. Moving the body can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Resources from Leukemia & Lymphoma Society
A new Bloodline podcast episode from the Leukemia & Lymphoma Society (LLS), features the topic of exercise. Moving the body can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Resources from Leukemia & Lymphoma Society
A new Bloodline podcast episode from the Leukemia & Lymphoma Society (LLS), features the topic of exercise. Moving the body can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park...
Vestibulum Malesuada Non Magna Lacinia
Home Office
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Resources from Leukemia & Lymphoma Society
A new Bloodline podcast episode from the Leukemia & Lymphoma Society (LLS), features the topic of exercise. Moving the body can be an important part of cancer recovery, both physically and emotionally. In this episode, Dr. Shernan Holtan of Roswell Park...
Accelerate the Cure News
Accelerate the Cure is much more than a campaign slogan. It’s our next 31 million USD effort, over five years, to find a cure and support those with WM and their caregivers. Global researchers have a new set of WM research targets, and they are afire with excitement....
2024 Walk for Waldenstrom’s Launches
Now that the 2024 Walk for Waldenstrom’s has officially launched, we're lacing up our shoes, starting fundraisers, and spreading the word that we will find a cure. Every year, during Blood Cancer Awareness Month, September 2024, we come together to show our support...
August Is National Make-A-Will Month
Did you know August is National Make-A-Will Month? By creating your will this month, you can get peace of mind for the future, protect your family, and support the future of the IWMF. Nearly 67% of American adults don't have a will, and we’re sharing a free, online...
Our Recommended Products
Shop
